Hans de Haard

4PUBLICATIONS
26CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)Molecular targetsAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 14, 2022
The Fab region of IgG impairs the internalization pathway of FcRn upon Fc engagement.

Maximilian Brinkhaus, Erwin Pannecoucke, Elvera J van der Kooi

|Nov 11, 2021
Anti-C2 Antibody ARGX-117 Inhibits Complement in a Disease Model for Multifocal Motor Neuropathy.

Kevin Budding, Lill Eva Johansen, Inge Van de Walle

|Sep 12, 2020
Selective inhibition of TGF-β1 produced by GARP-expressing Tregs overcomes resistance to PD-1/PD-L1 blockade in cancer.

Grégoire de Streel, Charlotte Bertrand, Nicolas Chalon

|Dec 11, 2019
Phase 2 study of efgartigimod, a novel FcRn antagonist, in adult patients with primary immune thrombocytopenia.

Adrian C Newland, Blanca Sánchez-González, László Rejtő

Pageof 1